Onderneming Cancer Prevention Pharmaceuticals Inc
Aandelen
CPP
US13740W1071
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Eugene W. Gerner
FOU | Founder | 76 | 09-06-08 |
Jeffrey Jacob
CEO | Chief Executive Officer | 62 | 09-06-08 |
Alfred M. Cohen
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Operating Officer | - | - | |
Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jon Saxe
BRD | Director/Board Member | 88 | 23-07-15 |
Richard L. Love
BRD | Director/Board Member | 81 | 01-11-11 |
Jeffrey Jacob
CEO | Chief Executive Officer | 62 | 09-06-08 |
Eugene W. Gerner
FOU | Founder | 76 | 09-06-08 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 6 759 443 | 4 226 504 ( 62,53 %) | 0 | 62,53 % |
Bedrijfsgegevens
Cancer Prevention Pharmaceuticals, Inc.
1760 East River Road Suite 250
85718, Tucson
+520 908 7774
http://www.canprevent.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,81% | 115 mld. | |
+12,90% | 107 mld. | |
-13,55% | 22,31 mld. | |
-3,99% | 21,6 mld. | |
-6,59% | 18,23 mld. | |
-39,93% | 17,62 mld. | |
+6,93% | 14,26 mld. | |
+33,06% | 12,37 mld. | |
-28,05% | 8,28 mld. |